cytarabine and Genetic Predisposition

cytarabine has been researched along with Genetic Predisposition in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (4.55)	18.2507
2000's	11 (50.00)	29.6817
2010's	8 (36.36)	24.3611
2020's	2 (9.09)	2.80

Authors

Authors	Studies
Hirschberg, CB	1
Jabbour, EJ; Kadia, TM; Kantarjian, HM; Rausch, CR	1
Arber, DA; Erba, HP	1
Cao, HX; Miao, CF; Sun, L; Tang, P; Yan, L; Zhang, LR	1
Cao, S; Cen, LN; Chen, P; Chen, SP; Chen, XP; Liu, H; Liu, YL; Yan, H; Zeng, H; Zhang, DY; Zhao, XL; Zhou, G; Zhu, KW	1
Gou, H; Hu, X; Lu, X; Peng, W; Shang, M; Song, X; Ye, Y; Ying, B; Zhang, J; Zhao, Z; Zhou, J; Zhou, Y	1
Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR	1
Azevedo, EA; Coelho-Silva, JL; Franca, RF; Franca-Neto, PL; Hemmelgarn, BT; Krause, A; Lange, AP; Lucena-Araujo, AR; Morais-Sobral, MC; Paiva, HH; Pereira-Martins, DA; Rego, EM; Scheucher, PS; Silva, CL; Thomé, C	1
Bellaaj, H; Elloumi, M; Kallel, C; Kammoun, H; Kassar, O; Sandi, HS	1
Abdulghaffar, EE; Abou El Asrar, M; Adly, AA; El-Bostany, EA; El-Ghouroury, EA; Tantawy, AA	1
Hasegawa, R; Kamatani, N; Kaniwa, N; Kawamoto, M; Kim, SR; Kim, WY; Lee, SJ; Lee, SS; Okuda, H; Saito, Y; Sawada, J; Shin, JG; Sugiyama, E; Tohkin, M	1
Dhall, G; Ettinger, LJ; Lastra, C; Mahadeo, KM; Panigrahy, A	1
Kimoto, Y; Moritake, H; Nunoi, H; Sawa, D; Shimonodan, H; Yamada, A	1
Bruyere, H; Copland, M; Hogge, DE; Horsman, DE; Lavoie, JC; Le, A; Nantel, SH; Nevill, TJ; Seftel, MD; Shepherd, JD; Sutherland, HJ; Toze, CL	1
Go, RS; Johnston, KL	1
Allen, SL; Archer, KJ; Baldus, CD; Bloomfield, CD; Caligiuri, MA; Carroll, AJ; de la Chapelle, A; Kolitz, JE; Larson, RA; Marcucci, G; Moore, JO; Powell, BL; Ruppert, AS; Tanner, SM; Vardiman, JW; Whitman, SP	1
Gratwohl, A; Rimner, T; Tichelli, A; Went, P	1
Buck, SA; Chen, Q; Diakiw, AE; Dombkowski, AA; Ge, Y; LaFiura, KM; Matherly, LH; Payton, SG; Salagrama, S; Taub, JW	1
Lange, B	1
Cordone, I; De Cuia, R; Fenu, S; Guerrisi, V; Mandelli, F; Mauro, FR; Meloni, G; Pescarmona, E; Proia, A; Reato, G	1
Aranoff, GS; Feldstein, NA; Garvin, JH; Hays, AP; Levine, LS; Oberfield, SE; Silfen, ME; Starkman, HS; Wong, B	1
Chang, EH; Cunningham, JM; Francis, GE; Holland, MJ; Pirollo, KF	1

Reviews

5 review(s) available for cytarabine and Genetic Predisposition

Article	Year
Golgi nucleotide sugar transport and leukocyte adhesion deficiency II. The Journal of clinical investigation, 2001, Volume: 108, Issue:1 Topics: Amino Acid Substitution; Animals; Arabs; Biological Transport; Carbohydrate Metabolism, Inborn Errors; Carrier Proteins; Cell Line; Child, Preschool; Consanguinity; Dimerization; DNA Mutational Analysis; Dogs; Ethnicity; Eukaryotic Cells; Fetal Growth Retardation; Fucose; Genetic Heterogeneity; Genetic Predisposition to Disease; Glycoproteins; Glycosylation; Golgi Apparatus; Guanosine Diphosphate Fucose; Humans; Infections; Intellectual Disability; Invertebrates; Lectins; Leukocyte-Adhesion Deficiency Syndrome; Male; Mammals; Monosaccharide Transport Proteins; Nucleoside Diphosphate Sugars; Phenotype; Point Mutation; Protein Processing, Post-Translational; Recurrence; Selection, Genetic; Turkey	2001
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC). American journal of clinical pathology, 2020, 11-04, Volume: 154, Issue:6 Topics: Aged; Aminopyridines; Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Cytarabine; Cytogenetic Analysis; Daunorubicin; DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Prognosis; PubMed; Triazines	2020
[Klinefelter syndrome and acute myeloblastic leukaemia]. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 8; Cytarabine; Cytogenetics; Genetic Predisposition to Disease; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Klinefelter Syndrome; Leukemia, Myeloid, Acute; Male; Trisomy	2009
Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome. European journal of haematology, 2003, Volume: 70, Issue:4 Topics: Abnormalities, Multiple; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Cytokines; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Menorrhagia; Neoplasm Proteins; Platelet Count; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Recurrence; Remission Induction; Risk; Syndrome; Thrombocytopenia	2003
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. British journal of haematology, 2000, Volume: 110, Issue:3 Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Female; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Leukemia; Leukemia, Myeloid; Male; Maternal Age; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine	2000

Trials

1 trial(s) available for cytarabine and Genetic Predisposition

Article	Year
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood, 2003, Sep-01, Volume: 102, Issue:5 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Treatment Outcome	2003

Article

Year

BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.

Blood, 2003, Sep-01, Volume: 102, Issue:5

Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Treatment Outcome

2003

Other Studies

16 other study(ies) available for cytarabine and Genetic Predisposition

Article	Year
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management. Cancer, 2020, 03-15, Volume: 126, Issue:6 Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Constipation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Monitoring; Fusion Proteins, bcr-abl; Genetic Predisposition to Disease; Humans; Injections, Spinal; Intercellular Signaling Peptides and Proteins; Kidney; Methotrexate; Ophthalmic Solutions; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein-Tyrosine Kinases; Vincristine	2020
Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients. Journal of translational medicine, 2017, Nov-15, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Binding Sites; Biomarkers, Tumor; Cytarabine; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Inactivation, Metabolic; Leukemia, Myeloid, Acute; Male; Metabolic Networks and Pathways; MicroRNAs; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Young Adult	2017
Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML). Journal of translational medicine, 2018, 04-10, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Cytarabine; Disease-Free Survival; Female; Gene Expression Regulation, Leukemic; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Nucleotides; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Quantitative Trait Loci; Remission Induction; Young Adult	2018
The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Proteins; China; Cytarabine; Daunorubicin; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Mutational Analysis; Female; fms-Like Tyrosine Kinase 3; Gene Frequency; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Proteins; Nuclear Proteins; Nucleophosmin; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-kit; Retrospective Studies; Treatment Outcome; Young Adult	2016
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, 2017, Volume: 102, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53	2017
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Oncotarget, 2017, Jan-31, Volume: 8, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Transplantation; Cathepsin G; Cell Differentiation; Cell Proliferation; Cell Self Renewal; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Gene Expression Regulation, Leukemic; Genetic Predisposition to Disease; Leukemia; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Neoplastic Stem Cells; Phenotype; Promyelocytic Leukemia Protein; Retinoic Acid Receptor alpha; Signal Transduction; Time Factors; Transfection; Tumor Protein p73; Up-Regulation	2017
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1 Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Egypt; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Mercaptopurine; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Proteins; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Stomatitis; Vincristine	2010
Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene. Drug metabolism and pharmacokinetics, 2009, Volume: 24, Issue:6 Topics: Alleles; Antimetabolites, Antineoplastic; Antirheumatic Agents; Asian People; Black or African American; Black People; Cytarabine; Cytidine Deaminase; Deoxycytidine; Gemcitabine; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; White People	2009
Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct end Pediatric hematology and oncology, 2010, Volume: 27, Issue:1 Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Daunorubicin; Endothelium, Vascular; Epilepsy, Tonic-Clonic; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Injections, Spinal; Leukoencephalopathies; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Sinus Thrombosis, Intracranial; Vincristine	2010
Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease. American journal of hematology, 2012, Volume: 87, Issue:4 Topics: Antimetabolites, Antineoplastic; Biomarkers; Biomarkers, Tumor; Cytarabine; Cytokines; Disease Progression; Down Syndrome; Drug Monitoring; Female; GATA1 Transcription Factor; Genetic Predisposition to Disease; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukemia, Megakaryoblastic, Acute; Mucin-1; Myeloproliferative Disorders; Neoplasm Proteins; Prednisone; Pulmonary Fibrosis; Remission Induction	2012
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22). European journal of haematology, 2002, Volume: 69, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Female; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Tumor Lysis Syndrome	2002
Concomitant hairy cell and acute myeloid leukemia. European journal of haematology, 2006, Volume: 76, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Daunorubicin; Genetic Predisposition to Disease; Humans; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Stem Cell Transplantation	2006
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy. Leukemia, 2008, Volume: 22, Issue:3 Topics: Acute Disease; Cell Differentiation; Child; Chromosomes, Human, Pair 21; Cytarabine; Daunorubicin; Down Syndrome; Drug Resistance, Neoplasm; Erythroid Precursor Cells; Erythropoiesis; GATA1 Transcription Factor; Gene Dosage; Gene Expression Regulation, Leukemic; Genetic Predisposition to Disease; Humans; K562 Cells; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Megakaryocytes; Neoplasm Proteins; Proto-Oncogene Mas; Proto-Oncogene Protein c-ets-2; Thrombopoiesis	2008
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:11 Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Fatal Outcome; Genetic Predisposition to Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Recombinant Proteins; Risk; Smoking; Transplantation Conditioning; Transplantation, Autologous; Vidarabine	2000
Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diabetes Insipidus; Disease Progression; Doxorubicin; Dwarfism, Pituitary; False Negative Reactions; Genetic Predisposition to Disease; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Hypothyroidism; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Pituitary Hormones; Pituitary Neoplasms; Prednisone; Remission Induction; Vincristine	2001
Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer. British journal of cancer, 1991, Volume: 63, Issue:1 Topics: Amsacrine; Ataxia Telangiectasia; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; Cytarabine; Cytoplasm; DNA Repair; DNA Topoisomerases, Type II; DNA, Circular; DNA, Superhelical; Female; Fibroblasts; Gene Expression; Genetic Predisposition to Disease; Humans; Male; Neoplasms; Oncogenes; Radiation Tolerance; Teniposide; Topoisomerase II Inhibitors	1991